SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy -- Ignore unavailable to you. Want to Upgrade?


To: Todd A. Sinelli who wrote (104)3/6/1998 6:03:00 PM
From: deadstrait  Read Replies (1) | Respond to of 184
 
I think it must be the gambler which is inside all of us. If we each
didn't have a little of him , we wouldn't be in the market in the first
place.
But, I have to say, I wouldn't want to be short this stock. Certainly
not with FDA approval pending on both their Thymo and SANG35. This
approval could come within days.
Obviously, the short interest is betting that it won't happen, and the
longs are betting that it will.
When,(and again I am saying "when") the approval is given, you should
see shorts covering at a break neck pace. The reason I say "when" is
that in my research I have found absolutely no reason for it not to
happen.
Perhaps as the time draws near, some shorts are getting nervous.
It could be that we saw a little covering today.

Good Luck
Dead